Medicine Man Technologies Inc. (OTCQX:MDCL) signed binding term sheet to acquire MedPharm Holdings LLC on January 10, 2019. The term sheet provided for the issuance of shares of common stock to MedPharm at an initial price per share of $1.32, with the final price to be determined based on the fair market valuation, which is subject to an independent valuation assessment. In related transactions, Medicine Man Technologies Inc. entered into term sheets to acquire FutureVision 2020, LLC and Futurevision Ltd., Inc. (doing business as Medicine Man); and MX LLC. The acquisition is subject to various terms and the satisfaction of various conditions, including obtaining the approval of Medicine Man Technologies shareholders, completion of financial audits, completion of due diligence and execution of definitive agreements between the respective parties and will also require the approval of the Marijuana Enforcement Division, as well as local city and county rules concerning the transfer and sale of ownership interest to have their licenses assigned to MDCL. The acquisition is expected to close sometime in the first quarter of 2019. As of April 23, 2019, the transaction is expected to close in June 2019.